ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 210 filers reported holding ARGENX SE in Q4 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,668,101 | +12.0% | 3,393 | -11.2% | 2.15% | +20.0% |
| Q2 2023 | $1,489,158 | +5.0% | 3,821 | +0.4% | 1.79% | -8.7% |
| Q1 2023 | $1,417,667 | -51.5% | 3,805 | -50.7% | 1.96% | -30.1% |
| Q4 2022 | $2,924,189 | +12.9% | 7,719 | +5.2% | 2.81% | +12.7% |
| Q3 2022 | $2,591,000 | -10.3% | 7,338 | -3.8% | 2.49% | -20.8% |
| Q2 2022 | $2,890,000 | -34.2% | 7,628 | -45.2% | 3.15% | +3.1% |
| Q1 2022 | $4,391,000 | -48.2% | 13,925 | -42.4% | 3.05% | -25.0% |
| Q4 2021 | $8,473,000 | +82.1% | 24,196 | +57.0% | 4.07% | +97.0% |
| Q3 2021 | $4,654,000 | +23.0% | 15,410 | +22.7% | 2.06% | +18.3% |
| Q2 2021 | $3,783,000 | +25.8% | 12,564 | +15.1% | 1.74% | -1.8% |
| Q1 2021 | $3,006,000 | +16.2% | 10,917 | +24.1% | 1.78% | -9.9% |
| Q4 2020 | $2,587,000 | – | 8,798 | – | 1.97% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 297,701 | $112,778,070 | 70.21% |
| Artia Global Partners LP | 85,204 | $32,277,831 | 12.30% |
| Avoro Capital Advisors LLC | 1,265,555 | $479,430,201 | 7.16% |
| DCF Advisers, LLC | 25,000 | $9,470,750 | 6.40% |
| Eagle Health Investments LP | 60,300 | $22,843,449 | 5.27% |
| Avidity Partners Management LP | 625,000 | $236,768,750 | 5.13% |
| Bellevue Group AG | 911,100 | $345,152,013 | 4.58% |
| Fairmount Funds Management LLC | 73,526 | $27,853,855 | 4.42% |
| Paradigm Biocapital Advisors LP | 89,556 | $33,926,499 | 3.98% |
| RTW INVESTMENTS, LP | 482,195 | $182,669,932 | 3.73% |